24-norursodeoxycholic acid

Known as: 24-Norcholan-23-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7beta)-, nor-UDCA 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
01219932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND & AIM Primary sclerosing cholangitis (PSC) represents a devastating bile duct disease, currently lacking effective… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2015
Review
2015
Primary sclerosing cholangitis (PSC) represents a fibro-obliterative bile duct disease with unpredictable individual clinical… (More)
Is this relevant?
Review
2014
Review
2014
Chronic inflammatory bile duct diseases such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) result… (More)
Is this relevant?
Review
2011
Review
2011
BACKGROUND Primary sclerosing cholangitis (PSC) remains a challenging disease to manage. The main goals are prevention of disease… (More)
Is this relevant?
2010
2010
UNLABELLED NorUDCA (24-norursodeoxycholic acid), the C₂₃-homolog of ursodeoxycholic acid (UDCA), showed remarkable therapeutic… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
UNLABELLED 24-norursodeoxycholic acid (norUDCA), a side chain-modified ursodeoxycholic acid derivative, has dramatic therapeutic… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2009
2009
Patients with chronic cholestatic diseases of the biliary tree, such as primary sclerosing cholangitis (PSC), have long suffered… (More)
  • figure 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND & AIMS Current therapy for primary sclerosing cholangitis is of limited efficacy. Multidrug resistance gene 2 knockout… (More)
Is this relevant?
2002
2002
In this study, we compared in vitro calcium binding by the taurine and glycine conjugates of the major bile acids in human bile… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?